additional structural details for this metabolite, additional quantities were generated from rat liver microsomal incubations and purified by HPLC for NMR analysis. The NMR data for the metabolite confirmed that the glucuronide was covalently bound to either the sulfur or the nitrogen of the benzoxazine-2-thione moiety. The lack of key through-bond (scalar) and throughspace (dipolar) 1-and 2-D NMR couplings and correlations in the metabolite spectra (due primarily to low sample concentration) precluded an unambiguous structure elucidation. Tanaproget is a potent, first-in-class nonsteroidal progesterone receptor agonist being investigated at Wyeth for use in contraception Zhang et al., 2005) . Earlier studies indicated that a major conjugated metabolite (>10%), referred to here as M1, was formed in rat and human liver microsomal incubations, and initially characterized by LC/MS as a glucuronide of tanaproget. The glucuronic acid group was proposed to be either on the nitrogen or the sulfur of the benzoxazine-2-thione moiety of tanaproget, 1, (Scheme 1). Oxidative metabolism represented a minor metabolic pathway of 1 in both in vitro and in vivo studies.
Analysis of the initial NMR data of M1 from rat liver microsomes confirmed that the glucuronide was covalently bound to either the S-or the N-of the benzoxazine-2-thione moiety.
However, due to an insufficient amount (~few µg) of the sample in solution, we could not record complete scalar and dipolar 1D and 2D NMR couplings and correlations for an unambiguous structure elucidation. The NMR analysis was especially challenging due to the lack of protons in the benzoxazine-2-thione moiety, particularly in the scenario of an S-glucuronide conjugate of tanaproget, since most heteronuclear correlations between the sugar and the parent molecule would be too long range to be observed.
Because of the challenges in preparing sufficient quantities of M1, the strategy turned away from liver microsome preparations to synthesis. Comparison of NMR, LC/MS, and HPLC data between synthetic compounds and M1 isolated from microsomes facilitated the unambiguous regio-and stereochemical assignment of the metabolite.
The present study highlights the successful approach and powerful utility of extensive NMR analysis and the availability of synthetic metabolite standards in the unambiguous identification of this S-linked metabolite. The data are critical for the drug development of tanaproget, since it would allow for biological testing of its major metabolite. This article has not been copyedited and formatted. The final version may differ from this version. dropwise. The reaction solution was then warmed to room temperature, and stirred for a total of 8 h. The reaction solution was partitioned between water (100 mL) and ethyl acetate (100 mL).
The aqueous layer was extracted again with ethyl acetate (100 mL). The combined organic layers were washed with saturated sodium chloride solution (100 mL), dried (magnesium sulfate), and solvent removed in vacuo to yield 0.350 g of crude reaction material. To a portion of this material (0.210 g) was added a solution of methanol/Hunig's base ((iso-Pr) 2 NEt)/water (5 mL/2 mL/2 mL) and the solution was stirred for 8.5 h at room temperature. The reaction solution was then adjusted to pH 2.5 using HCl (conc., approximately 1.5 mL) and chromatographed by 6 and 15 mg of 3, the S-glucuronic acid derivative (10% isolated yield from tanaproget), were purified to > 98% purity based on NMR analysis.
Preparation of Tanaproget Glucuronide Conjugate from Rat Liver Microsomes for
NMR. Liver microsomes from Sprague-Dawley rats were prepared in-house using a differential ultracentrifugation method (Lake, 1987) with slight modifications. Microsomal protein and cytochrome P450 content were determined by previously published methods (Bradford, 1976; Omura and Sato, 1964) . The protein concentration and P450 content were 50.9 mg/mL and 0.42 nmol/mg protein, respectively. Incubations (100 mL) were performed with tanaproget (40 µM), UDPGA (5 mM), magnesium chloride (10 mM), and male rat liver microsomes (1.5 mg/mL), in 0.1 M potassium phosphate buffer, pH 7.4 at 37 °C. The samples were pre-incubated for 1 min at 37 °C, and the reactions were initiated by the addition of UDPGA. Incubation mixtures were placed on ice to stop the reaction after 3 h. Tanaproget was removed from the incubate by ether extraction (200 mL x 2). Tanaproget glucuronide, and remaining tanaproget were extracted using C18 cartridges and elution with methanol. The eluate was dried by rotary evaporation at room temperature. The residues were extracted with 50% acetonitrile in water (5 mL). Aliquots of supernatants were analyzed on a Waters 2690 HPLC system with a semi-preparative column.
Separation was accomplished on a Luna column (C18, 250 x 10 mm ID, 5 µm, Phenomenex, Torrance, CA) and metabolites were detected by UV absorbance at 310 nm. The autosampler temperature was 6 o C, and the column was at room temperature. Ammonium acetate (10 mM, pH 4.5) and acetonitrile were used as mobile phase A and B, respectively. The following gradient removed by rotary evaporation. The glucuronide was extracted from the aqueous eluates by solid phase extraction using C18 cartridges. Water was used to wash residual buffer and 50% methanol in water was used to elute the glucuronide conjugate, M1. The methanol/water eluates were dried by rotary evaporation at room temperature followed by lyophilization. LC/MS. LC/MS data for the synthetic compounds were acquired using a Waters Alliance 2695 HPLC coupled to a Waters ZQ mass spectrometer using an open-access LC/MS method previously described (Mallis et al., 2002) . The LC/MS system used for M1 analysis was a Waters Alliance model 2695 HPLC coupled to a Micromass Quattro Ultima triple quadrupole mass spectrometer (Waters). Separations were accomplished on a Phenomenex Luna C18 (2) column ( A 1 H NMR spectrum of M1 is shown in Figure 1A and a compilation of the results from NMR experiments on M1 is given in Table 1 . Despite several attempts at using freshly isolated M1 samples, the purity and concentration of the samples were typically low (< 70% pure and an (Martin et al., 2003; Ethell et al., 2003) .
HPLC comparisons were made to confirm whether the major synthetic glucuronide of tanaproget, S-glucuronide 3, was identical to M1, now proposed to be the S-glucuronide from the NMR and mass spectral results described above. Five different types of reverse phase HPLC columns, as described in Materials and Methods, were each used under two different mobile phase gradient conditions, as follows. One mobile phase was a gradient of 10 mM ammonium acetate in water/acetonitrile (90/10 to 10/90 in 20 minutes), and the other mobile phase was a gradient of 10 mM formic acid in water/acetonitrile (90/10 to 10/90 in 20 minutes). These ten HPLC conditions covered a wide range of selectivity as evidenced by the change of elution order of the major and minor components in the samples. To compare and match the retention time of the major peaks in the two samples, spiking experiments were performed. The synthetic glucuronide 3 that was determined to be S-glucuronide was found to have identical retention times as metabolite M1 under all ten HPLC conditions.
Literature reports of glucuronide conjugation through an S-linkage are rare (Ethell et al., 2003; Jeffcoat et al., 1980; Martin et al., 2003; Nakaoka et al., 1989; Smith et al., 1992) , with (Green and Tephly, 1998; Hawes, 1998; Kuehl and Murphy, 2003; Tricker, 2003) . We recently reported that UGT1A9 and 2B7 were the major isoforms involved in the formation of tanaproget Sglucuronide (Elmarakby et al., 2005) .
Direct NMR structure elucidation of the metabolite M1 generated from rat liver microsomal incubation was challenging because of the lack of protons proximal to the glucuronic acid group attached to the benzoxazine-2-thione moiety of tanaproget which, therefore, precluded homonuclear correlations to the attached sugar group. The lack of NOEs from the sugar to the remainder of the molecule constituted only negative proof that M1 was an S-glucuronide and not an N-glucuronide. Further, chemical shift arguments for the benzoxazine-2-thione carbonyl and the glucuronic acid group were also insufficient evidence for an unambiguous structure proof. Synthetic compounds turned out to be a more straightforward path to structure elucidation, since they could be made in relatively pure, concentrated amounts.
In summary, from extensive chromatographic and spectral comparison of the microsomally derived metabolite M1 and the synthetic compounds 2 and 3, the glucuronide metabolite of tanaproget has been determined to be the S-β-(D)-glucuronide conjugate.
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